E. Robinson

发表

Synthesis of N-alkyl substituted indolocarbazoles as potent inhibitors of human cytomegalovirus replication.

R. Baxter, W. Snowden, M. Slater, 2001, Bioorganic & medicinal chemistry letters.

Structure-activity relationships within a series of caspase inhibitors: effect of leaving group modifications.

J. Díaz, A. Schmitz, T. Deckwerth, 2003, Bioorganic & medicinal chemistry letters.

Addressing species specific metabolism and solubility issues in a quinoline series of oral PDE4 inhibitors.

B. Judkins, T. Shipley, A. Craven, 2010, Bioorganic & medicinal chemistry letters.

First-in-class pan caspase inhibitor developed for the treatment of liver disease.

N. Chen, J. Díaz, K. Valentino, 2005, Journal of medicinal chemistry.

Oxamyl dipeptide caspase inhibitors developed for the treatment of stroke.

A. Sauter, J. Díaz, A. Schmitz, 2004, Bioorganic & medicinal chemistry letters.

A mild method for the synthesis of furans. Application to 2,5-bridged furano macrocyclic compounds

J. A. Marshall, E. Robinson, J. Marshall, 1990 .

Fructose-1,6-bisphosphatase inhibitors. 1. Purine phosphonic acids as novel AMP mimics.

M. Erion, Q. Dang, P. D. van Poelje, 2009, Journal of medicinal chemistry.

Synthesis of the tumor-inhibitory tobacco constituents .alpha.- and .beta.-2,7,11-cembratriene-4,6-diol by diastereoselective [2,3] Wittig ring contraction

J. A. Marshall, J. Lebreton, E. Robinson, 1990 .

Stereoselective total synthesis of β-2,7,11-Cembratriene-4,6-diol (β-CBT), a tumor inhibitory constituent of tobacco smoke

R. D. Adams, J. A. Marshall, E. Robinson, 1988 .

Enantioselective total synthesis of (+)-α-2,7,11-cembratriene-4,6-diol(α-CBT)

J. A. Marshall, E. Robinson, 1989 .

Furans in synthesis. 11. Total syntheses of (.+-.)- and (-)-fastigilin C

W. Watt, M. McMills, E. Robinson, 1992 .

[2,3] Wittig rearrangement of nonracemic propargyl ethers leading to allenes of high stereochemical integrity

J. A. Marshall, A. Zapata, E. Robinson, 1989 .

Synthesis of 6-hydroxycembrane precursors by conformationally controlled diastereoselective [2,3] wittig ring contraction

J. A. Marshall, J. Lebreton, E. Robinson, 1988 .

Cyclopentane construction with control of side-chain configuration: enantioselective synthesis of (+)-brefeldin A

D. Taber, E. Robinson, L. J. Silverberg, 1991 .

Optimization of Novel Indazoles as Highly Potent and Selective Inhibitors of Phosphoinositide 3-Kinase δ for the Treatment of Respiratory Disease.

P. Jones, P. Rowland, N. Parr, 2015, Journal of medicinal chemistry.

Structure-activity relationships within a series of caspase inhibitors. Part 2: Heterocyclic warheads.

N. Chen, J. Díaz, A. Schmitz, 2005, Bioorganic & medicinal chemistry letters.

Bis[(para-methoxy)benzyl] phosphonate prodrugs with improved stability and enhanced cell penetration.

M. Erion, Q. Dang, P. D. van Poelje, 2007, Bioorganic & medicinal chemistry letters.

Acyl dipeptides as reversible caspase inhibitors. Part 2: further optimization.

N. Chen, J. Díaz, A. Schmitz, 2002, Bioorganic & medicinal chemistry letters.